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Host and bacterial determinants for
colonisationStaphylococcus aureus is a common human commensal but carriage varies between e.g. geographic loca-
tion, age, gender, ethnicity and body niche. The nares, throat and perineum are the most prevalent sites
for carriage in the general adult population. Other sites of the skin and the intestine are also frequently
colonised. Thus, a successful establishment is dependent on multiple factors. This review describes
results from observational studies of S. aureus carriage and the inﬂuence bacterial, host and environmen-
tal/modiﬁable factors might have on the relationship.
 2013 Elsevier B.V.Open access under  CC BY-NC-ND license.1. Introduction
Staphylococcus aureus is very well adapted to colonise the hu-
man skin, and our bodies probably provide some major ecological
niches for this species. We are daily exposed to the bacteria, but
still only some people are carriers over longer periods of time. Car-
riage is asymptomatic, not harmful per se and could even to some
extent be protective for a host if infected by S. aureus (Wertheim
et al., 2004; Verkaik et al., 2009). However, carriers are at risk of
autoinfection that requires speciﬁc attention in connection to hos-
pitalisation and major surgery (Wertheim et al., 2004; von Eiff
et al., 2001; Kluytmans et al., 1995). In addition, emergence and
spread of antimicrobial resistance, such as methicillin resistant S.
aureus (MRSA) have aggravated the situation. According to ECDC,
MRSA is the most prevalent antimicrobial resistant bacterium iso-
lated in hospitals in Europe, the Americas, North Africa and the
Middle- and Far East (ECDC, 2012).
Commensal bacteria have to balance the lifestyle between efﬁ-
cient surface adherence, to avoid removal by mechanical forces,
and not being recognised and destroyed by the host’s innate and/
or adaptive immune systems. For S. aureus this is challenged by
their own ability to express an arsenal of virulence factors that in-
duce host cell and tissue damage which in turn would stimulate an
immediate immune response (Vandenesch et al., 2012). Thus, vir-
ulence has to be tightly down regulated during colonisation. Simi-
larly, gene products that are beneﬁcial for colonisation, such as
adhesion and/or immune evasion proteins (Burian et al.,2010a,b), and probably also gene products that protect against
the reactive oxygen species and desiccation have to be up-
regulated (Cosgrove et al., 2007).
There are numerous reports of factors associated with S. aureus
colonisation and a reasonable review could by no means include
them all. Thus, we have focused on a few important ﬁndings
including the most relevant literature only. This review aims to de-
scribe and discuss results from observational studies of S. aureus
carriage and the inﬂuence bacterial, host and environmental/mod-
iﬁable factors might have on the relationship.2. S. aureus carriage
2.1. Carriage niches
Already in the late 19th century staphylococci were shown to
be responsible for furunculosis, but the fact that some individuals
were predisposed for the infection and that it could occur without
any contact with other infected people remained unexplained for
decades. Thus, dyscrasia (bad blood mixture) seemed to be the
most plausible cause at that time. Weak and anaemic persons
and people with metabolic diseases (e.g. diabetes and gout/arthri-
tis urica) were known to have reduced resistance to staphylococcal
disease. It was also known that itching skin lesions, lice and scabies
were linked to staphylococcal skin infections. In 1932 the Norwe-
gian dermatologist and Professor Niels Danbolt could show that 22
out of 24 patients with recurring furunculosis had staphylococci
with the same biochemical properties both in the nose and in the
lesions (Danbolt, 1932). Thus, Danbolt suggested that the nasal
‘‘infection’’ was responsible for the recurrent skin infection indicat-
ing autoinfection. In 1948 Moss and colleagues showed that skin
carriage of S. aureus was dependent on nasal carriage in patients
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treatment, could reduce nasal S. aureus carriage from 97% to 37%
and simultaneously reduce skin carriage from 57% to 38% after
15 days (Moss et al., 1948). They suggested that the nasal vestibule
was the primary site of S. aureus carriage. Further investigations
have conﬁrmed that the most frequent site of carriage is the ante-
rior nares of the nose (Williams, 1963). These, and other studies,
were extended by Cole and co-workers who pinpointed the moist
squamous epithelium on the septum adjacent to the nasal ostium
to be the main colonisation site in carriers (Cole et al., 2001b).
In the general adult population, S. aureus can also commonly be
found at other body sites such as the axillae (8%), chest/abdomen
(15%), perineum (22%), intestine (17–31%) (Williams, 1963), and
vagina (5%) (Guinan et al., 1982). Pharyngeal carriage has been re-
ported to be highly variable between populations (4–64%) (Wil-
liams, 1963) but this difference might be due to differences in
sampling techniques. Interestingly, recent reports have shown
higher carriage rates in the throat than in the nares when sampled
in parallel (see below). Also, an intestinal carriage of 20% in healthy
individuals has been reported and although nasal carriage may
predispose to intestinal carriage, sole intestinal carriage was also
detected (Acton et al., 2009). In an MRSA screening performed at
The University Hospital of Lausanne a total of 12456 individuals
were sampled in the nose, groin and throat. The sensitivity of
detection by culture was 48%, 63% and 61% for the three sampling
sites, respectively. Combinations of two sites increased the sensi-
tivity to 76–89% while inclusion of all three sites increased it to
96% (Senn et al., 2012). These results suggested a broader prefer-
ence of S. aureus for colonisation than previously deﬁned, at least
for MRSA. This is also in line with clinical guidelines for the detec-Table 1
Selected studies of S. aureus nasal carriage.
Country Participants type Year
China Preclinical medical students May 2008-OCT 2009
French Guiana Remote population Oct 2006-Jun 2008
Gabon General population Feb-July 2009
India Parents at well baby clinic
Indonesia Patients on admission; patients
being discharged; ambulatory
patient; patients relatives
Jul 2001-May 2002
Japan Healthy students and staff 2001
Kenya Health care workers May–Dec 2010
Malaysia Healthy volunteers
Mexico General population 1998–2006
Norway Random visitors at shopping
centre
2001–2005
Norway The Tromsø Staph and Skin
Study; general population;
Oct 2007–Dec 2008
Pakistan Healthy volunteers Jan 2002–Dec 2003
Sweden Orthopaedic ward; patients and
Health care workers
March–Sept 2003
Switzerland Overall
Blood donors
Dental patients
Health Care Workers
Patients + Health Care Workers
2000–2006
Taiwan Community residents, patients
and health care workers
Apr–Oct 2001
The Netherlands The Rotterdam Study; general
population
Apr 1997–Dec 1999
The Netherlands General non-surgical hospital
population
Feb 1999–Feb 2001
The Netherlands The generation R Study; mother
and child pairs
Tunisia Healthy volunteers Oct 2008–Feb 2009
USA NEHANES; general population 2001–2004
a NC, nasal carriage.
b Reported persistent carriage.tion of MRSA (Ringberg et al., 2006; Mertz et al., 2007; The Norwe-
gian Institute of Public Health and The Norwegian Directorate of
Health, 2009).2.2. Carriage types
In general, S. aureus carriage is determined by single nasal sam-
pling but from longitudinal studies with multiple samplings three
types of carriage patterns, i.e. persistent, intermittent and non-
carriage has been suggested (Williams, 1963). In Nouwen et al.,
2004a,b tested a ‘‘culture rule’’ for a valid determination of the
three types. From two nasal cultures obtained at a one week inter-
val individuals were deﬁned as persistent (two S. aureus positive
cultures), intermittent (one S. aureus positive culture) or non-car-
rier (no positive S. aureus culture). The positive predictive value
was 0.79 and the negative predictive value was 0.99 (Nouwen
et al., 2004a). Persistent carriers also seem to have a signiﬁcantly
higher S. aureus load in the nares than intermittent carriers (White,
1961; Nouwen et al., 2004a). However, a reclassiﬁcation of inter-
mittent to non-carriers was recently suggested. From a 22 week’s
follow-up study of volunteers that were artiﬁcially inoculated with
a mixture of S. aureus strains it was shown that intermittent and
non-carriers shared similar nasal elimination kinetics. The average
post-inoculation carriage period was 4 and 14 days for non- and
intermittent carriers in comparison to 154 days for persistent car-
riers (van Belkum et al., 2009). Samples from persistent carriers
also had on average a higher cfu per swab in comparison to sam-
ples from intermittent carriers. From serum samples it was found
that persistent carriers had signiﬁcantly higher anti-staphylococcal
antibody titres than non- and intermittent carriers (van BelkumN= Age NCa Reference
2103 19–23 years 23.1% (Ma et al., 2011)
163 18–81 years 41.7%
57.8%
(Ruimy et al., 2010)
500 1–90 29% (Ateba Ngoa et al., 2012)
319 Adults 29.4% (Saxena et al., 2003)
3995 9.1% (Lestari et al., 2008)
157 Adults 35.7% (Uemura et al., 2004)
246 18.3% (Omuse et al., 2012)
346 Adults 23.4% (Choi et al., 2006)
1243 1–96 years 37.1% (Hamdan-Partida et al., 2010)
348 15–90 years 27.3% (Skramm et al., 2011)
4026 30–87 years 27.6% (Sangvik et al., 2011)
1660 14.8% (Anwar et al., 2004)
346 Mean 71 years 32% (Nilsson and Ripa, 2006)
3464
1500
498
634
832
37–81 years 36.4%
37.5%
31.9%
37.4%
36.2%
(Mertz et al., 2009)
2231 1–93 years 24.1% (Lu et al., 2005)
3851 61–101 years 18%b (Emonts et al., 2008)
14008 24% (Wertheim et al., 2004)
511 Mother
Child 2 years
25.2%
13.5%
(Lebon et al., 2010)
423 13.0% (Ben Slama et al., 2011)
18626 1–P 60 years 30.4% (Gorwitz et al., 2008)
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intermittent carriers and should form a separate category. The two
latter types seem very similar and could be grouped as one.2.3. Carriage prevalence
S. aureus nasal carriage among the general adult population
shows global variation. Selected studies of nasal carriage are listed
in Table 1. For Western Europe carriage rates were found to be 24–
25.2% in The Netherlands (Wertheim et al., 2004; Lebon et al.,
2010), 27.3–27.6% in Norway (Skramm et al., 2011; Sangvik
et al., 2011) and 36.4% in Switzerland (Mertz et al., 2009). From
The National Health and Nutrition Examination Survey (NHANES)
in USA the prevalence was reported to be 30.4% in the period
2001–2004 (Gorwitz et al., 2008). Similar rates were found among
healthy Japanese volunteers showing a nasal carriage of 35.7%
(Uemura et al., 2004) while in China the prevalence of nasal S. aur-
eus was only 23.1% among 2103 preclinical medical students (Ma
et al., 2011). For South and Southeast Asia quite variable carriage
rates have been found; 9.1% in Indonesia (Lestari et al., 2008),
14.8% in Pakistan (Anwar et al., 2004), 23.4% in Malaysia (Choi
et al., 2006), 24.1% in Taiwan (Lu et al., 2005) and 29.4% in India
(Saxena et al., 2003). Recent reports from Africa show carriage
rates of 13.0% in Tunisia (Ben Slama et al., 2011), 29% in Gabon
(Ateba Ngoa et al., 2012) and 18.3% in Kenya (Omuse et al.,
2012). In Mexico carriage was reported to be 37.1% (Hamdan-Part-
ida et al., 2010), while within a remote adult population in the
Amazonian forest the overall carriage was as high as 41.7% in
2006 and 57.8% in 2008 (Ruimy et al., 2010).
More recent studies have indicated the importance of throat
colonisation. At a Swedish orthopaedic ward throat carriage was
signiﬁcantly higher than nasal carriage rate both for patients
(40% vs. 31%) and staff (54% vs. 36%); exclusive throat carriage
was observed among 36.0% of patients and 42.6% of staff carrying
S. aureus (Nilsson and Ripa, 2006). In a Swiss study of risk factors
for S. aureus throat carriage, including 3464 subjects, the preva-
lence of exclusive throat carriage was 30.2% among colonised indi-
viduals from the community and 18.4% among hospitalised
patients and health care workers (HWCs) (Mertz et al., 2009). In
a study from Mexico samples from 1234 healthy individuals
showed that S. aureuswas more frequently isolated from the throat
(46.5%) than in the nose (37.1%) and among the colonised individ-
uals as much as 38% were exclusive throat carriers (Hamdan-
Partida et al., 2010). These ﬁndings are in concordance with the
screening data mentioned above that suggested a broader prefer-
ence than just nasal colonisation for S. aureus (Senn et al., 2012).
MRSA seems to colonise the same body niches as any S. aureus
and the most prevalent site varies between studies as for MSSA. In
a general Mexican population MRSA was more frequently recov-
ered from positive nasal than positive throat samples, 32.9% and
23%, respectively (Hamdan-Partida et al., 2010). The opposite was
found at The University Hospital of Lausanne where MRSA was
more frequently identiﬁed in throat swabs (15% positive for MRSA)
than in nasal swabs (12% positive for MRSA; (Senn et al., 2012).
However, throat carriage of MRSA requires special attention since
it has been found to be associated with eradication failure (Amme-
rlaan et al., 2011).3. Determinants for colonisation
Successful S. aureus colonisation is the outcome of a process
determined by multiple factors that contribute to the host–mi-
crobe interaction. Bacterial determinants deﬁne S. aureus’ ability
to adhere to human tissue and evade host immunity. Host geneticsdeﬁne the human predisposition for colonisation. Environmental
factors modify the host, microbe and host–microbe interaction.
3.1. Bacterial determinants
Traditionally S. aureus isolates have been deﬁned to have either
carriage or clinical origin. But this has been questioned and com-
parative genomics has rather indicated the opposite. By microarray
analysis comparing 61 community-acquired invasive isolates and
100 nasal carriage isolates of S. aureus 10 dominant lineages were
identiﬁed. However, no association between lineage or gene and
invasive isolates could be identiﬁed thus suggesting that the gene
combinations required are the same for colonisation and invasion
(Lindsay et al., 2006). There was also no signiﬁcant difference
found in the prevalence of genes encoding the adhesive proteins
SdrC, SdrD and SdrE between carrier (N = 259) and invasive isolates
(N = 141) from different countries (Sabat et al., 2006). These data
were conﬁrmed by a genomic comparison of S. aureus isolates with
genotype USA300 from skin abscesses, nose and rectum of 57 chil-
dren. The results showed that the genomic content of isolates from
all three sites was indistinguishable and no niche speciﬁc determi-
nants were detected (Lemmens et al., 2011).
Others have compared isolates by speciﬁc sequence analysis.
Comparisons of seven MLST gene fragments and the hypervariable
regions of clumping factor and ﬁbronectin binding protein genes
(clfA, clfB, fnbA, fnbB) obtained from 56 nasal carriage isolates, 28
clinical isolates and 15 complete S. aureus genomes in the NCBI
database indicated that nasal strains are genetically related to
those responsible for high levels of morbidity and mortality. Both
nasal carriage strains and clinical strains exhibited the same genet-
ic makeup in housekeeping and virulence genes (Lamers et al.,
2011). Thus, any isolate could be either colonising or invasive
and the degree of success would be deﬁned by the host. Still pop-
ulation dynamic studies reveal that certain clonal complexes are
more prominent than others, both in carriage and invasive disease
(Sangvik et al., 2011; Yeung et al., 2011).
S. aureus is able to colonise different sites of the human body
that involves a wide variety of interactions. A limited number of
bacterial encoded determinants have been shown to be expressed
in vivo and only a few have been conﬁrmed to be involved in nasal
colonisation of humans. Direct transcript analyses by quantitative
RT-PCR analyses on nasal swabs from four persistent carriers re-
vealed prominent expression of S. aureus genes encoding adhesive
molecules (clfB, isdA, fnbA, atlA, eap), genes involved in Wall Tei-
choic Acids (WTA) biosynthesis (tagO and tarK), cell surface
dynamics/remodelling enzymes (sceD, oatA, atlA) and immune-
modulatory factors (sak, chp, spa, eap) during nasal colonisation
in humans. In contrast, the major toxin genes (hla, psm) were not
found to be transcribed under these conditions (Burian et al.,
2010b). Consistent with these ﬁndings the virulence regulator
encoding genes agr, sigB and sae were not induced in nasal secre-
tions. All together the gene expression detected suggests that S.
aureus is actively growing, ready to adhere and not preparing for
a virulent activity when present in nasal secretions and/or
epithelium.
Human skin provides a physical permeability barrier as well as
a chemical antimicrobial barrier and bacterial determinants such
as WTA have been shown in vitro to protect S. aureus against anti-
bacterial fatty acids (AFA) produced by human sebaceous glands
(Kohler et al., 2009). Another important example is IsdA, the major
S. aureus surface protein induced by Fe-limiting conditions (Clarke
et al., 2004). IsdA was found to confer AFA resistance in vitro and in
a human skin survival model two independent isdA knock-out mu-
tants showed signiﬁcantly reduced survival in comparison to their
isogenic wild type strains (Clarke et al., 2007). IsdA has also been
shown to bind lactoferrin in vitro and protect S. aureus against
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tions from humans (Clarke and Foster, 2008). IsdA reveals multiple
functions in the host microbe interaction serving both as an adhe-
sive surface protein as well as modulator of host defences.
The S. aureus clumping factor B (ClfB) is a ﬁbrinogen binding
protein in vitro (Ni Eidhin et al., 1998; Perkins et al., 2001) which
also binds to cytokeratin 10 expressed on squamous cells (O’Brien
et al., 2002; Walsh et al., 2004) and cytokeratin 8 expressed on epi-
thelial cells (Haim et al., 2010). Recently ClfB was suggested to play
a role in bioﬁlm formation in vitro (Abraham and Jefferson, 2012).
Interestingly, ClfB was shown to be necessary for S. aureus nasal
colonisation in humans after artiﬁcial inoculation of 16 healthy
volunteers (Wertheim et al., 2008). The mutant strain lacking the
clfB gene was eliminated signiﬁcantly faster from the nose than
its isogenic wild-type strain, and it was concluded that ClfB is a
major determinant in human nasal S. aureus carriage. On the
contrary the type B immune evasion cluster (IEC), encoding the
chemotaxis inhibitory protein (CHIPS), staphylococcal complement
inhibitor (SCIN) and staphylokinase (SAK) located on the b-
haemolysin converting bacteriophage bC-U13 was found to have
a negative inﬂuence on nasal colonisation in 20 healthy volunteers.
The time for elimination after artiﬁcial inoculation was signiﬁ-
cantly reduced from 14 to 4 days when the bacteriophage was
present in the genome (Verkaik et al., 2011).
Additional S. aureus adhesins i.e. SdrC, SdrD and SasG have been
suggested to participate in human colonisation and have been
shown to speciﬁcally bind to squamous cells in vitro (Corrigan
et al., 2007; Corrigan et al., 2009). WTA was also shown to confer
binding to the human nasal epithelial cells (Weidenmaier et al.,
2004) and S. aureus deﬁcient in WTA synthesis was found to have
58% reduced binding to primary human nasal squamous epithelial
cells compared to wild type, conﬁrming a role of WTA in adhesion
in vitro (Weidenmaier et al., 2008).
Bioﬁlm formation has been suggested to have implications on S.
aureus colonisation (Quinn et al., 2009; Iwase et al., 2010) but inde-
pendent observations from human studies point to a rather dis-
persed mode of growth in the vestibulum nasi not consistent
with a bioﬁlm community (Krismer and Peschel, 2011). Among
chronic rhinosinusitis patients on the other hand, non-invasive S.
aureus bioﬁlm growth was identiﬁed by FISH in 13 out of 20 indi-
viduals in vivo and bioﬁlmmatrix polysaccharide poly-N-acetylglu-
cosamine (PNAG) was detected in 12 of the patients (Foreman
et al., 2013). Bioﬁlms that could harbour S. aureus were also de-
tected on adenoid tissues from children with recurrent and/or
chronic otitis media (Kania et al., 2008) as well as adenoid and ton-
sil tissues from patients without clinical signs of infection (Kania
et al., 2008; Swidsinski et al., 2007). Thus, bioﬁlm formation might
also be relevant for S. aureus colonisation of at least some human
body niches.
For successful establishment in the human nares, S. aureusmust
interact and compete with a wide variety of co-colonising microor-
ganisms. Culture based methods for analyses of screening samples
are labour intensive and always limited by the growth conditions
selected such as e.g. aerobic growth. Still, speciﬁc microbial inter-
ferences have been reported. In children there are evidences for an
inverse correlation between S. aureus and Streptococcus pneumo-
niae carriage in the nasopharynx during the ﬁrst year of life (Lebon
et al., 2011; van Gils et al., 2011). Among 156 healthy volunteers,
the presence of corynebacteria was associated with a reduced nasal
S. aureus colonisation, i.e. the incidence was 8.5% in the presence
and 44.5% in the absence of corynebacteria. This was also experi-
mentally supported by an artiﬁcial inoculation of a strain of Cory-
nebacterium sp that resulted in S. aureus eradication among 71% of
the colonised (Uehara et al., 2000). Some years later the opposite
i.e. a high frequency of Corynebacterium spp. in S. aureus carriers
was found among 216 healthy volunteers (Lina et al., 2003). Thelatter was recently supported by 16S rDNA sequencing of PCR
amplicons from nasal swabs of six individuals (Wos-Oxley et al.,
2010) suggesting a positive correlation between S. aureus and at
least some species of Corynebacterium. Finegoldia magna is another
ubiquitous skin anaerobe colonising epidermis (Frick et al., 2008;
Gao et al., 2007; Higaki and Morohashi, 2003). A clear negative cor-
relation was found between S. aureus and F. magna in nasal swabs
from 40 individuals analysed by single strand conformation poly-
morphism (Wos-Oxley et al., 2010). Recently isolates of Staphylo-
coccus epidermidis were also found to negatively interfere with S.
aureus nasal colonisation and the inhibitory activity was deﬁned
to a serine protease named Esp (Iwase et al., 2010). Culture-
independent analyses of 16S rRNA sequences from microbes in
the human nares of healthy adults (N = 5) collected longitudinally
and from a cross section of hospitalised patients (26 S. aureus car-
riers, and 16 non-carriers) was performed. A negative association
between S. aureus and S. epidermidis in the inpatient population
without further deﬁning the inhibitory determinant was identiﬁed
(Frank et al., 2010).
Application of high throughput sequencing has made compara-
tive microbiome studies feasible and it is now possible to get a
broader insight into the ecosystems of various colonisation niches
and conditions on the human body. Because of the huge amount of
data produced most studies are limited to genera descriptions and
only a few reports present species speciﬁc information. 16S rDNA
sequences from nasal communities of six healthy volunteers re-
vealed a low diversity with a high abundance of a few species
(Wos-Oxley et al., 2010).
3.2. Host genetic determinants
Human determinants that give rise to individual variation in
bacterial colonisation are likely to be molecular changes that alter
adhesive properties, recognition and/or eradication. The informa-
tion presented from epidemiological studies has rarely been at
the molecular level, but have provided valuable data showing asso-
ciations between host determinants and S. aureus carriage. Only re-
cently single nucleotide polymorphism (snp) analyses and genome
wide association studies (GWAS) were applied to identify genetic
markers linked with S. aureus carriage. Interestingly, no signiﬁcant
heritability for S. aureus carriage was detected within a Danish co-
hort of 617 middle-aged and elderly twin pairs (Andersen et al.,
2012). Still, there are reports of allelic variants of deﬁned factors
involved in adhesion, recognition or host responses that are asso-
ciated with increased carriage rates.
The human skin provides a barrier against microbe invasion.
The uppermost part, the epidermis, consist of several layers of
keratinocytes in various differentiation states, interspersed with
other cell types like melanocytes, Langerhans-, Merkel- and T cells
(Hari et al., 2010). The epithelium is stratiﬁed forming stratum ba-
sale, stratum spinosum, stratum granulosum and stratum cor-
neum. As a consequence of differentiation from stratum basale
and up to stratum corneum, the cells start synthesising ﬁlagrin,
loricrin, involucrin as well as proteases like stratum corneum chy-
motryptic protease/kallikrein 7 and stratum corneum tryptic en-
zyme/kallikrein-5. In stratum corneum, the cells are terminally
differentiated and anucleated, surrounded by an intercellular ma-
trix enriched in no-polar lipids (Candi et al., 2005; Proksch et al.,
2008). The structure creates a physical barrier to the environment,
and also prevents water loss from the organism (transepidermal
water loss) (Proksch et al., 2008).
Any bacterium colonising the human skin is confronted by the
host immune systems and primarily the innate immunity. The cells
in epidermis express pattern recognition receptors, like Toll-like
receptors (TLRs) and nucleotide-binding oligomerization domain
(NOD)-like receptors. After recognition of pattern-associated
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tion receptors (PRRs) trigger production of antimicrobial peptides
(AMPs) and/or cytokines (Froy, 2005; Hari et al., 2010; Lai and Gal-
lo, 2009; Nakatsuji and Gallo, 2012; Yamasaki and Gallo, 2008).
Structural and/or functional alterations in molecules contributing
to these processes could possibly inﬂuence the persistence of S.
aureus carriage. Toll-like receptor (TLR) 2 is one of the human PRRs
deﬁned to speciﬁcally recognise components of the Gram positive
cell wall (Hari et al., 2010). One snp in TLR2, altering an arginine
residue in position 753 to a glutamine, has been shown to impair
intracellular signalling and possibly affecting infection susceptibil-
ity (Lorenz et al., 2000). In a study of 3 months old healthy children
in Finland the odds ratio (OR) for S. aureus colonisation in the naso-
pharynx was 2.91 [95% Conﬁdence Interval (CI) 1.17–7.26] for het-
erozygotes in comparison to homozygotes for Arg753 suggesting a
reduced S. aureus recognition by the Gln753 variant of TLR2
(Vuononvirta et al., 2011).
The AMPs produced in human skin includes cathelicidins,
defensins, dermcidin, ribonuclease 7 (RNase 7), psoriasin, lactofer-
rin and others (Nakatsuji and Gallo, 2012). The expression of AMPs
can be constitutive or induced upon sensing of danger, which in-
volves signalling through PRRs or cytokine response (Lai and Gallo,
2009). In addition to have an antimicrobial effect, the AMPs can
inﬂuence the host cells. As such, alternative terms for AMPs have
appeared, and these include ‘‘host defence peptides’’, ‘‘defensins’’
or ‘‘alarmins’’ (Nakatsuji and Gallo, 2012). Chemokines have also
been reported to inhibit bacterial growth, including staphylococci,
at least in vitro (Yang et al., 2003; Cole et al., 2001a; Yung et al.,
2011).
Cathelicidin is transcribed from a single gene in human, CAMP
(cathelicidin antimicrobial peptide), which results in an 18 kDa
pro-protein referred to as hCAP18 (human cationic antimicrobial
protein 18 kDa). hCAP18 is stored in granules within keratinocytes,
and secreted into spinous and granular layer of epidermis. The lo-
cal proteases kallikrein-5 and -7 cleave the pro-protein into the ac-
tive antimicrobial peptides LL-37, RK-31 and KS-30 (Yamasaki and
Gallo, 2008). LL-37 level was determined among 12 healthy control
individuals and 13 patients with chronic rhinosinusitis. Higher LL-
37 concentrations in nasal secretions were observed among
healthy S. aureus carriers compared to non-carriers (Thienhaus
et al., 2011).
a- and b-defensins are also expressed as pro-proteins, which
will be post-translationally cleaved into active AMPs. Trypsin is in-
volved in cleavage of the former, while the enzymes involved in
cleavage of b-defenins in skin remain to be identiﬁed (Nakatsuji
and Gallo, 2012; Gallo and Hooper, 2012). The defensins genes
are clustered in chromosome 8p23.1, and the copy numbers of
defensins genes vary between individuals (Yamasaki and Gallo,
2008). However, no associations between copy number and/or se-
quence variations of human neutrophil peptides 1–3 (HNP1-3) or
b-defensin-3 and nasal carriage of S. aureus have been found (Fode
et al., 2011; van Belkum et al., 2007). Still, the expression level of
AMPs may differ among carriers and non-carriers. Indeed, when
comparing 30 persistent and 30 non-carriers it was shown that in-
duced expression of b-defensin 3 mRNA in skin from nasal carriers
were 63% (P = 0.02) whereas non-induced expression was 76%
(P = 0.14) of that found in non-carriers (Zanger et al., 2011). In a re-
cent study among 603 volunteers, b-defensin-1 (DEFB1) promoter
haplotype (ACG versus GGG at the positions 52/44/20) was
associated with an almost doubled risk of S. aureus nasal carriage
(OR = 1.93, 95% CI 1.2–3.1) and reduced expression of b-defensin-1
(P < 0.001) and 3 (P = 0.04) in samples of experimentally
wounded skin (Nurjadi et al., 2013).
RNase 7 is expressed in all epidermal layers of healthy human
skin, but is mostly expressed in the upper more differentiated lay-
ers (Harder et al., 2010; Koten et al., 2009). A study including 40control individuals and 20 travellers returning with S. aureus posi-
tive skin infections, revealed that the expression of RNase 7 was
64% higher in unaffected skin compared to the infected skin
(P = 0.007) (Zanger et al., 2009). However, no association of consti-
tutive RNase 7 mRNA expression was found in a study where 30
nasal carriers were compared with 30 non-carriers (Zanger et al.,
2011).
Glucocorticoids are recognised immune suppressors used in
treatment of inﬂammatory and autoimmune diseases, and organ
transplantation. Individual variation in cortisol levels, sensitivity
and responsiveness could inﬂuence infection susceptibility. Inter-
estingly, among elderly people within the Rotterdam Study homo-
zygotes of haplotype 3 (G–A–C–G) of the glucocorticoid receptor
(GR) gene had a 68% reduced risk of persistent nasal carriage
(OR = 0.32, 95% CI 0.13–0.82) while a combination of haplotype 1
and 5 (G–A–C–A and A–A–C–G) increased the risk of persistent na-
sal S. aureus carriage by 80% (OR = 1.80, 95% CI 1.08–3.00) (van den
Akker et al., 2006). Thus, the individual glucocorticoid sensitivity
and subsequent inﬂammatory response might also inﬂuence bacte-
rial colonisation. However, cortisol levels did not differ between 38
non-carriers, 10 intermittent carriers and 24 persistent carriers
(P = 0.638) (Manenschijn et al., 2012).
Other components involved in the inﬂammatory response have
also been found to inﬂuence S. aureus carriage. Mannose-binding
lectin (MBL) contributes to the innate immunity by binding to var-
ious bacteria and thus promoting opsonophagocytosis (Neth et al.,
2002). Homozygosity for one of the minor alleles is known to al-
most abolish serum MBL completely and has been associated with
a 75% increased risk of nasopharyngeal S. aureus carriage in infants
when 412 subjects were analysed (OR = 1.75, 95% CI 1.09–2.81)
(Vuononvirta et al., 2011). The opposite was found for nasal colo-
nisation among adult and elderly healthy volunteers (N = 109)
where the wild type MBL was more frequent among persistent na-
sal carriers than among non-carriers (87% vs. 67%, P = 0.038) (van
Belkum et al., 2007). Among 3851 elderly participants in the Rot-
terdam Study, homozygotes for C/C in position 524 of the interleu-
kin-4 gene had a 72% increased risk of nasal carriage (OR = 1.72,
95% CI 1.3–2.5) (Emonts et al., 2008). The authors suggest that de-
creased mucociliary clearance of S. aureusmight play a role as indi-
viduals with the C-allele have lower IL-4 serum concentration and
lower mucin production (Biesbrock et al., 1991). For the C-reactive
protein (CRP) those with the haplotype 1184C; 2042C; 2911C had
and OR of 0.89 (95% CI 0.7–1.1) and 0.64 (95% CI 0.4–0.9) for per-
sistent carriage with 1 or 2 copies, respectively vs. no copies
(Emonts et al., 2008). In an analysis of 111 volunteers homozygotes
for the snp resulting in a valine instead of methionine in position
480 of the serine protease C1 inhibitor, a regulator of the comple-
ment cascade, were shown to be over-represented among non-
carriers when compared to the general population (72.0% vs.
55.5%, P = 0.02) (Emonts et al., 2007).
Carbohydrate modiﬁcations and secretion of host cell surface-
proteins, such as the histo-blood group antigens, have impact on
bacterial adhesion and colonisation. In a study among 227 individ-
uals, blood group 0 was associated with a 6.5 times increased risk
of being a S. aureus throat carrier in comparison to blood group A
(OR = 6.50, 95% CI 1.28–33.03) (Nurjadi et al., 2012). Allelic varia-
tions in the gene encoding the histocompatibility antigen (HLA)
have also been found to inﬂuence nasal S. aureus carriage. In a
study of healthy laboratory workers (N = 90) and patients visiting
an outpatients clinic (N = 90) the HLA-DR3 allele was found to be
associated with carriage (relative risk (RR) = 1.9; P < 0.05) while
HLA- Bw35, HLA-DR1 and HLA-DR2 were all associated with
non-carriage (RR = 0.3–0.5; P < 0.05) (Kinsman et al., 1983).
Serum vitamin D levels have been inversely related to S. aureus
carriage among non-smoking men in the population-based Tromsø
Staph and Skin Study (P = 0.001); serum 25(OH)D concentration
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reduced risk of S. aureus carriage (OR = 0.52; 95% CI 0.31–0.90) (Ol-
sen et al., 2012). An inverse association between vitamin D levels
and risk of MRSA was observed in a study including 14,000 chil-
dren and adults across USA (Matheson et al., 2010). In this study
there was no association for overall S. aureus carriage, but possible
interactions by sex and age group were not examined. Also, a small
retrospective study of patients with S. aureus infection, showed a
link between low vitamin D status and adverse outcome (Youssef
et al., 2010). Vitamin D has direct effects on immunity modulated
by the vitamin D receptor (VDR) present in immune cells. Binding
of VDR to its responsive element induces expression of antimicro-
bial peptides (i.e. cathelicidin and b-defensin) with activity against
S. aureus in vitro (Schauber and Gallo, 2008; White, 2010). Genetic
polymorphisms in VDR have been associated with the risk of S. aur-
eus carriage in 93 patients with type 1 diabetes mellitus (DM)
(Panierakis et al., 2009). However, among 1547 participants in
the Rotterdam study, no associations between VDR polymorphisms
and S. aureus carriage were observed (Claassen et al., 2005).
3.3. Chronic inﬂammation
An acute inﬂammation will either be resolved and return to
homeostasis or persist in the tissue. The chronic inﬂammatory re-
sponse can have a genetic origin and/or be induced by modiﬁable
factors.
Skin diseases that alter the epithelium might inﬂuence S. aureus
carriage. Atopic dermatitis (AD) is a pruritic skin disease character-
ised by barrier dysfunction of the skin and chronic inﬂammation
(Bieber, 2008). The altered skin structure of AD patients mainly
caused by reduced levels of lipids (ceramide, sphingosine) and dis-
turbed expression of host proteins such as ﬁlagrin, loricrin or invo-
lucrin, or proteases like kallicrein, in the stratum corneum, the
outer layer of the skin barrier. Overexpression of kallicrein-7, for
example, negatively interferes with desmosomes between the cor-
neocytes, thereby interfering with the physical barrier (van Bever
and Llanora, 2011). Lack of ﬁlagrin results in reduced level of the
breakdown products urocanic acid (UCA) and pyrrolidone carbox-
ylic acid (PCA), which in addition to hydration may also be in-
volved in pH regulation of the skin and have an antimicrobial
effect towards S. aureus (Miajlovic et al., 2010). Several genetic loci
have been found associated to AD including genes encoding cyto-
kines, chemokines and receptors of the immune system (Bieber,
2008). The Gln753 variant of TLR2 was reported to be more preva-
lent among AD patient than controls and was found associated
with a more severe phenotype (Ahmad-Nejad et al., 2004). Also,
selective impairment of TLR2–mediated pro-inﬂammatory cyto-
kine production by monocytes has been suggested to explain an in-
creased susceptibility to S. aureus in patients with AD (Hasannejad
et al., 2007). Moreover, it has been reported that the sweat of AD
patients has decreased levels of dermcidin, a peptide with activity
against S. aureus, compared with the sweat of healthy subjects
(Rieg et al., 2005).
Several smaller clinical studies have shown strong associations
between AD and S. aureus colonisation of the skin and nose (Leyden
et al., 1974; Gilani et al., 2005; Breuer et al., 2002). AD patients
show carriage rates between 39% and 90% (Bernard and Gallo,
2011; Balma-Mena et al., 2011), while 100% have S. aureus in their
active eczema lesions (Bieber, 2008; Leyden et al., 1974). Higher
AD severity score was associated with S. aureus colonisation in
some studies (Balma-Mena et al., 2011; Lebon et al., 2009). This
was conﬁrmed by a recent study of microbial community struc-
tures during disease ﬂares. The proportion of S. aureus in AD lesions
was higher than at baseline or post-treatment and this temporal
shift in the skin microbiome also correlated with disease severity
(Kong et al., 2012). However, others observed no association be-tween S. aureus load and disease severity (Harder et al., 2010).
Baseline expression of AMPs in lesion-free skin of AD subjects is
not different from that of normal skin of non-AD individuals (Harder
et al., 2010; Goo et al., 2010) but AD-patients were shown to have a
reduced human b-defensin (hBD)-2 immunereactivity when com-
pared to individuals with psoriasis (McGirt and Beck, 2006; Ong
et al., 2002). Lesional skin of AD patients also showed reduced
expression hBD-3 in comparison to that of psoriasis patients
(P < 0.01) (Howell et al., 2006). However, Recently AD lesions were
found to have increased expression of RNase 7, psoriasin, and hBD-
2 and -3 compared with psoriatic and healthy control skin (Asano
et al., 2008; Harder et al., 2010), while the secretion of AMPs was
not associated with S. aureus colonisation (Harder et al., 2010).
S. aureus colonisation can contribute to allergic sensitization
and inﬂammation. In a study staphylococcal enterotoxin B (SEB)
enhanced the allergen-speciﬁc T cell response (Ardern-Jones
et al., 2007). The increased amount of the ceramidase produced
by the bacteria can lead to increased defect in the barrier function.
Most patients with AD make speciﬁc IgE antibodies directed
against staphylococcal enterotoxins, which correlate with skin dis-
ease severity (Leung et al., 1993). Pruritus in AD is in part caused
by cytokines that may be up-regulated by staphylococcal entero-
toxins in vitro. Furthermore, by inﬂuencing the glucocorticoid
receptor in mononuclear cells the enterotoxins can induce steroid
resistance, a large clinical problem in dermatology (Hauk and Leu-
ng, 2001).
In psoriasis, another chronic inﬂammatory skin disease, the
keratinocytes hyperproliferates and the basal keratinocytes
reaches the surface within 6–8 days compared to approximately
40 days in normal skin. The epidermis also has abnormal expres-
sion of various epidermis speciﬁc proteins, and elevated levels of
AMPs are found (Roberson and Bowcock, 2010). Still, colonisation
of lesional skin and nares by S. aureus has been demonstrated in
50–64% of patients with psoriasis (Tomi et al., 2005; Balci et al.,
2009). S. aureus toxin positivity has been directly related to psori-
asis severity, supporting the hypothesis that exacerbation of psori-
atic lesions by S. aureus is most likely mediated via toxin secretion
(Leung et al., 1993; Balci et al., 2009). According to this, it has been
postulated that enterotoxins-induces activation of T-lymphocytes
play a critical role in subgroups of patients with chronic plaque
psoriasis (Sayama et al., 1998; Balci et al., 2009). The question
has arisen whether enterotoxins produced by S. aureus induce a
skin seeking phenotype of lymphocytes which again drive the local
inﬂammation process.
3.4. Other risk factors
S. aureus carriage varies with age. At birth babies are readily col-
onised but nasal carriage rates signiﬁcantly decrease during the
ﬁrst year of life from 53.8% at 1.5 months to 22.9% at 6 months
to only 11.9% at 14 months of age (The Generation R Study)(Lebon
et al., 2008; Lebon et al., 2010). Similar results were previously
shown for nasopharyngeal carriage (Harrison et al., 1999). The
prevalence of S. aureus in nasopharynx in small children is quite
stable between 20% and 30% until it jumps to 40–50% and remains
there from age 6 to 12 years of age after which it gradually de-
creases down to approximately 25% at age 18 (Bogaert et al., 2004).
Larger population-based cross-sectional studies have reported
higher risk of S. aureus nasal carriage among men as compared
with women (OR from 1.5 to 1.81) (Zanger et al., 2012; Graham
et al., 2006; Lebon et al., 2008; Olsen et al., 2009). Both data from
the US National Health and Nutrition Examination Survey 2001–02
(N = 9622; age > 1 year) and the more recent Tromsø Staph and
Skin Study in 2007–08 (N = 3989; age 30–87 years) suggest inter-
action by age with the largest sex differences in carriage rates in
younger adulthood and similar sex-speciﬁc carriage rates in
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Moreover, data from the large NHANES sample suggest interaction
between sex and race/ethnicity; male gender was a signiﬁcant risk
factor for S. aureus carriage in the non-Hispanic white and Mexican
American populations but not in the non-Hispanic black popula-
tion (Kuehnert et al., 2006). Being non-Hispanic white compared
to non-Hispanic black seems to be a risk factor for S. aureus car-
riage among men (OR = 1.7, 95% CI 1.4–2.0), but not among women
(Kuehnert et al., 2006).
Diabetic adults receiving insulin show a higher S. aureus car-
riage rate (34.0–53.4%) than healthy individuals (10.7–34.2%) (Ta-
mer et al., 2006; Smith and O’Connor, 1966; Tuazon et al., 1975)
which is in concordance with the increased risk of infection known
for DM patients. The reported risk ratio (RR) for DM patients to ob-
tain any infection was 1.21 (99% CI 1.20–1.22) (Shah and Hux,
2003), while the adjusted odds ratio for developing bacterial skin
an mucous membrane infection was 1.59 (95% CI 1.12–2.24) and
1.33 (95% CI 1.15–1.54) for patients with type 1 DM and type 2
DM, respectively (Muller et al., 2005). However, diabetics receiving
oral anti-diabetic agents have carrier rates similar to non-diabetic
individuals (11.0–35%) (Tamer et al., 2006; Smith and O’Connor,
1966; Tuazon et al., 1975) suggesting that DM per se is not respon-
sible. Importantly, however serum glucose levels were directly
associated with S. aureus carriage in a large population-based sam-
ple (Nouwen et al., 2004b).
In a prospective cohort study strong evidence for a role of exog-
enous steroid hormones in S. aureus colonisation in women was
provided (Zanger et al., 2012). When compared with women not
using hormonal contraceptives, women taking reproductive hor-
mones had an 88% increased risk of persistent S. aureus nasal car-
riage (N = 1180, OR = 1.88, 95% CI 1.29–2.75). This is in line with a
previous report of a statistically signiﬁcant higher odds of S. aureus
nasal carriage among oral contraceptive users (P = 0.035) (Choi
et al., 2006) .
There is evidence from large population-based studies for an in-
verse association between current smoking and S. aureus carriage
among both men and women; in the Rotterdam study smoking
was associated with a 36% reduced risk (OR = 0.64, 95% CI 0.49–
0.84) and in the Tromsø Staph and Skin Study the S. aureus carriage
rate was 28% lower in smokers than in non-smokers (P < 0.01) (Ol-
sen et al., 2012). Possible explanations for the suggested protective
effect of smoking include the bactericidal activity of cigarette
smoke (Wang et al., 2009) and the increased immune activity asso-
ciated with smoking-induced hypoxia.
Exposure to S. aureus is an important determinant for carriage.
S. aureus is acquired from sources in the environment, with human
carriers as the most important source. A typical transmission route
of S. aureus is from the nose to the hand of a person (Wertheim
et al., 2006), then to a surface (e.g. a door knob), and/or via the
hand to the nose of a second person. Activities involving close
physical contact and the risk of minor injuries, such as sports, are
positively correlated with S. aureus spread and acquisition (Kazak-
ova et al., 2005). Crowding and large family size with transmission
between household members have been identiﬁed as risk factors
for S. aureus nasal carriage (Mollema et al., 2010; Wagenvoort
et al., 2005). In parallel with demographic transition and socio-eco-
nomic development during the last century, there has been a drop
in the prevalence of S. aureus nasal carriage in the adult population
(Wertheim et al., 2004; Kluytmans et al., 1997), supporting a role
of living conditions, crowding and hygiene.
Healthcare workers (HCWs) and patients may be a reservoir for
S. aureus transmission in the hospital. There are several reports of
similar S. aureus nasal carriage rates among healthcare workers as
in the general population (Wertheim et al., 2004; Johnston et al.,
2007; Kluytmans et al., 1997; Mertz et al., 2009; Olsen et al.,
2013). However, level of patient contact maymodify the risk of col-onisation; in a US hospital, surgeons had higher S. aureus nasal car-
riage rates (35.7%) than high-risk patients (18%,
P < 0.01)(Schwarzkopf et al., 2010), and higher rates have been ob-
served among nurses than among other healthcare workers (Elie-
Turenne et al., 2010; Suffoletto et al., 2008). Also, in the Tromsø
Staph and Skin Study, a 54% increased risk of S. aureus nasal car-
riage was observed among female HCWs versus female non-HCWs
(OR = 1.54, 95% CI 1.09–2.19). For women residing with children,
HCWs had an 86% increased risk of S. aureus nasal carriage com-
pared to non-HCWs (OR 1.86, 95% CI 1.14–3.04) (Olsen et al.,
2013). Moreover, HCWs versus non-HCWs had a 2.17 and
3.16 times higher risk of spa types t012 and t015, respectively (Ol-
sen et al., 2013). Interestingly, in the study by Mertz and co-work-
ers exposure to the health care system (i.e. being HCWwith regular
patient contact, or inpatients/outpatients last 12 months) was
found to reduce the risk of exclusive throat carriage versus nasal
carriage by 33% (OR = 0.67, 95% CI 0.54–0.84) (Mertz et al., 2009).
HCWs are also at risk of MRSA exposure and subsequent carriage.
In an MRSA non-endemic hospital in Western Australia a total of
1542 HCWs were screened for MRSA. The overall colonisation rate
was 3.4% but MRSA colonisation was more common for patient
care assistants (6.8%) and nurses (5.2%) than for allied health pro-
fessionals (1.7%) and doctors (0.7%, P < 0.01) (Verwer et al., 2012).
The relation between throat carriage and exposure to the
healthcare system has also been studied. At a Swedish orthopaedic
ward throat carriage was signiﬁcantly higher than nasal carriage
both for patients (40% vs. 31%) and staff (54% vs. 36%) (Nilsson
and Ripa, 2006). Furthermore, exclusive throat carriage was re-
ported to be 17% and 26% for the patients and staff, respectively.
Exclusive throat carriage was also reported in a large Swiss cohort
including three groups of individuals from the community, differ-
ing in the estimated level of exposure to the health care system,
and a fourth group comprised of hospitalised patients and health
care workers (HWCs) (Mertz et al., 2009). But contrary to the
Swedish cohort exposure to the health care system seemed protec-
tive with an OR of 0.67 (P = 0.001). The most important risk factor
was age and 30 years or younger gave an OR of 1.66 (P < 0.001)
(Mertz et al., 2009). In a study from Mexico samples from 1234
healthy individuals showed that S. aureuswas more frequently iso-
lated from the throat (46.5%) than in the nose (37.1%) and 38%
were exclusive throat carriers (Hamdan-Partida et al., 2010).4. Summary and outlook
S. aureus is an important human pathogen that contributes sig-
niﬁcantly to morbidity and mortality in society. One important
prerequisite for infection is its ability to establish as a human com-
mensal. Thus, identiﬁcation of speciﬁc determinants for S. aureus
colonisation and carriage could provide tools for infection preven-
tion and/or treatment as well as means of predicting host suscep-
tibility. The carriage rate in the general population varies with
geographic location, age, sex, ethnicity and body niches. These
and other non-modiﬁable risk factors should be considered in the
study design and data analysis.
Even though the bacterium has been studied in detail, so far
only ClfB and IsdA have been shown to be associated with nasal
colonisation in vivo in humans. The recent application of microbi-
ome analyses will hopefully shed light on the bacterial ﬂora’s im-
pact and possibly speciﬁc bacteria-bacteria interactions that
inﬂuence S. aureus carriage.
Examples of human determinants that have been found to be
associated with S. aureus carriage are allelic variants of the genes
encoding TLR2, GR, MBL, Il-4, CRP, serine protease C1 inhibitor,
HLA, and VDR, all contributing to the innate immunity. Also
expression levels of AMPs and serum levels of vitamin D seem to
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matory response when exposed to S. aureus has been demonstrated
for the chronic inﬂammatory skin diseases such as AD and
psoriasis.
From population based studies a number of modiﬁable risk fac-
tors have been found associated with carriage, including oral con-
traceptives use, smoking, crowding and healthcare exposure.
However, to extract speciﬁc host determinants from available data
can be challenging. For example the dramatic variations in carriage
rates over short periods of life observed for children are likely to be
multifactorial and single determinants would be very hard to iden-
tify. Still, epidemiological studies can provide valuable information
for formulating hypothesis about factors that might be involved in
carriage.
Functional studies of speciﬁc determinants of S. aureus carriage
are necessary to understand the molecular interactions. In vivo
studies on human subjects are challenging and relevant animal
models to test deﬁned factors separately would be very informa-
tive. Selected host–microbe interactions should be conﬁrmed and
analysed in detail in vitro. Population based studies have always
been important for identiﬁcation of risk factors and could be fur-
ther reﬁned to reveal novel determinants.References
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